HKUMed researchers (IMAGE)

The University of Hong Kong

HKUMed researchers

Caption

The cb1 vaccine platform demonstrates a single, intranasally administered vaccine can confer wide-ranging immunity that may protect against both current and future beta-coronavirus spillovers, potentially eliminating the need for frequent vaccine updates.

Credit

The University of Hong Kong

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.